Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000905718-17-000794

Director sold 34,141 shares at an average $19.06 ($650,693)

From the SEC's structured data for this filing

Trades in this filing

EMSTER KURT VON · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-16 Sale : show line 1 in the form −20,548 $19.27 $395,960 2,096,883 I
2017-08-17 Sale : show line 2 in the form −13,593 $18.74 $254,733 2,083,290 I
Open-market sales · 34,141 sh · avg $19.06 · $650,693
Loading xslF345X03/vonemster_fm4aug162017.xml…